Results 131 to 140 of about 197,499 (175)

Long-acting growth hormone - the first year real-life experience

Česko-slovenská pediatrie
Jan Lebl, Irena Aldhoon Hainerová, Jana Černá, Eva El-Labibidi, Stanislava Koloušková, Ivana Kotvalová, Olga Magnová, Dana Novotná, Barbora Obermannová, Renata Pomahačová, Štěpánka Průhová, Ondřej Souček, Jiří Strnadel, Marta Šnajderová, Zdeněk Šumník, Jiřina Zapletalová   +15 more
openaire   +1 more source

Efimosfermin for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH): Mechanism of Action, Clinical Development and Emerging Therapeutic Potential. [PDF]

Drug Des Devel Ther
Alamgir M, Sohal A, Kowdley KV.
europepmc   +1 more source

MsDREB2A modulates alfalfa growth by regulating MsCRE1 involved in cytokinin biosynthesis. [PDF]

BMC Plant Biol
Kuang Q, He C, Ding R, Huang D, Huang H, Jiang H.   +5 more
europepmc   +1 more source

Reproductive and sexual sequelae of neuroendocrine tumour therapies: an under-recognised challenge. [PDF]

Endocr Relat Cancer
Shekhda KM, Shah PM, Biddanda A, Grossman A, Caplin M.   +4 more
europepmc   +1 more source

Growth hormone in disease and treatment (Review). [PDF]

Med Int (Lond)
Fakir S, Sarker MMR, Sigdel M, Barabutis N.   +3 more
europepmc   +1 more source

Long-Acting PEGylated Growth Hormone in Children with Idiopathic Short Stature: 2-Year Results.

Horm Res Paediatr
Hou L, Yang Y, Zhao S, Dong G, Chen L, Li P, Ma Y, Gong C, Luo F, Xu X, Gong H, Du H, Shi Q, Zhong Y, Chen X, Chen X, Xu L, Zhao J, Su C, Cheng R, Xu L, Zhang L, Luo X.   +22 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Status of long-acting-growth hormone preparations — 2015

Growth Hormone & IGF Research, 2015
Growth hormone (GH) treatment has been an established therapy for GH deficiency (GHD) in children and adults for more than three decades. Numerous studies have shown that GH treatment improves height, body composition, bone density, cardiovascular risk factors, physical fitness and quality of life and that the treatment has few side effects.
Charlotte Høybye, Pinchas Cohen, Andrew R. Hoffman, Richard Ross, Beverly M.K. Biller, Jens Sandahl Christiansen   +5 more
openaire   +5 more sources

Somapacitan: a long-acting growth hormone derivative for treatment of growth hormone deficiency

Drugs of Today, 2022
Growth hormone deficiency (GHD) is characterized by inadequate HG production from the anterior pituitary gland. Adult patients with GHD have increased fat mass, an abnormal lipid profile, decreased lean body mass and bone mineral density, decreased muscle strength and exercise endurance, and a diminished quality of life.
openaire   +2 more sources